Target intelligence / Profile preview

Alpha-2,6-linked sialic acid (N-acetylneuraminic acid) (Neu5Ac)

Target
Neu5Ac
Molecular classification
Carbohydrate, Glycan, Receptor
01

Overview

Human cell-surface sialic acid residues, specifically N-acetylneuraminic acid (Neu5Ac) with an alpha-2,6-linkage to galactose, serve as the primary attachment receptors for human influenza viruses. The viral surface glycoprotein hemagglutinin (HA) contains a specialized receptor-binding site (RBS) that recognizes these specific glycan structures on the host's respiratory epithelium to initiate viral attachment and subsequent endocytosis (Source: Nature, 2002). The prevalence and distribution of these alpha-2,6-linked residues in the human upper respiratory tract are critical determinants of the tissue tropism and efficient human-to-human transmission of seasonal influenza strains (Source: Science, 2006). Therapeutic strategies targeting these residues include the use of sialidases, such as the drug DAS181 (Fludase), which enzymatically remove the terminal sialic acids to prevent viral docking and infection (Source: Journal of Infectious Diseases, 2010). Beyond their role in viral pathogenesis, sialic acids are essential for various physiological processes, including the regulation of the immune system through interactions with Siglec receptors and the maintenance of the mucosal barrier (Source: Nature Reviews Immunology, 2014).

Other names
Sialic acidN-acetylneuraminic acidNeu5AcInfluenza receptorAlpha-2,6-Neu5AcHost cell sialic acid residues
02

Mechanism of action

Enzymatic removal of terminal sialic acid residues from the host cell surface to prevent viral hemagglutinin binding and entry.

03

Biological functions

Viral entryCell-cell interactionImmune response modulationSignal transductionProtein stabilization
04

Disease associations

InfectionInfluenzaParainfluenzaCancer
05

Safety considerations

Respiratory tract irritationPotential disruption of Siglec-mediated immune signalingIncreased risk of secondary bacterial infections (e.g., Streptococcus pneumoniae) due to altered mucosal surfaces
06

Interacting drugs

DAS181

1 more in the full profile.

07

Biomarkers

Alpha-2,6-sialyltransferase expression levelsSialic acid surface density in respiratory epithelium

Beyond the preview

Go deeper on Alpha-2,6-linked sialic acid (N-acetylneuraminic acid) (Neu5Ac).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-2,6-linked sialic acid (N-acetylneuraminic acid) (Neu5Ac).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call